IgG4-related disease

Joint Bone Spine

Volumn 81, Issue 1, 2014, Pages 27-31

  Palazzo, Elisabeth ^a   Palazzo, Clémence ^b   Palazzo, Maxime ^c  

^a Service de Rhumatologie   (France)

^b HÔpital Cochin   (France)

^c HÔpital Beaujon   (France)

Author keywords

Arthritis; Autoimmune pancreatitis; IgG4 related disease; Rituximab

Indexed keywords

AZATHIOPRINE; IMMUNOGLOBULIN G4; METHOTREXATE; PREDNISONE; RITUXIMAB; IMMUNOGLOBULIN G; AUTOANTIBODY; IMMUNOMODULATING AGENT; MYCOPHENOLATE MOFETIL;

ANTIGEN ANTIBODY COMPLEX; ARTHROPATHY; BILE DUCT DISEASE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G4 RELATED DISEASE; KIDNEY DISEASE; LACRIMAL GLAND DISEASE; LUNG DISEASE; LYMPHADENOPATHY; MEDIASTINUM DISEASE; MIKULICZ DISEASE; PANCREAS DISEASE; RETROPERITONEAL DISEASE; SALIVARY GLAND DISEASE; SHORT SURVEY; T LYMPHOCYTE; THYROID DISEASE; URINARY TRACT DISEASE; AUTOIMMUNE DISEASE; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; ACALCULOUS CHOLECYSTITIS; AUTOIMMUNE PANCREATITIS; CLINICAL ASSESSMENT; CORTICOSTEROID THERAPY; DIAGNOSTIC PROCEDURE; HISTOPATHOLOGY; LABORATORY TEST; NOMENCLATURE; PREVALENCE; PSEUDOTUMOR; SEX RATIO;

AUTOIMMUNE DISEASES; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED;

EID: 84893790339     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2013.06.001     Document Type: Short Survey

References (42)

1. Hamano H., Kawa S., Horiuchi A., et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001, 344:732-738.
2. Umehara H., Okazaki K., Masaki Y., et al. Comprehensive diagnostic criteria for IgG4-related disease 2011. Mod Rheumatol 2011, 22:21-30.
3. Kamisawa T., Kim M.H., Liao W.C., et al. Clinical characteristics of 327 Asian patients with autoimmune pancreatitis based on Asian diagnostic criteria. Pancreas 2011, 40:200-205.
4. Zen Y., Nakanuma Y. IgG4-related disease: a cross-reactional study of 114 cases. Am J Surg Pathol 2010, 34:1812-1819.
5. Mannion M., Cron R.Q. Successful treatment of pediatric IgG4-related systemic disease with mycophenolate mofetil: case report and a review of the pediatric autoimmune literature. Pediatr Rheumatol Online J 2011, 9:1-9.
6. Guma M., Firestein G.S. IgG4-related diseases. Best Pract Res Clin Rheumatol 2012, 26:425-438.
7. Kalaitzakis E., Webester G.J. Review article: autoimmune pancreatitis-management of an emerging disease. Aliment Pharmacol Ther 2010, 33:291-303.
8. Carruthers M.N., Stone J.H., Khosroshahi A. The latest on IgG4-RD: a rapidly emerging disease. Curr Opin Rheumatol 2011, 24:60-69.
9. Deshpande V., Zen Y., Chan J.K., et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012, 25:1181-1192.
10. Stone J.H., Khosroshahi A., Deshpande V., et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum 2012, 64:3061-3067.
11. Stone J.H. IgG4-related disease: nomenclature, clinical features, and treatment. Semin Diagn Pathol 2012, 29:177-190.
12. Matsubayashi H., Furukawa H., Maeda A., et al. Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis. Pancreatology 2009, 9:694-699.
13. Nakatani K., Nakamoto Y., Togashi K. Utility of FDG PET/CT in IgG4-related systemic disease. Clin Radiol 2012, 67:297-305.
14. Park D.H., Kim M.H., Chari S.T. Recent advances in autoimmune pancreatitis. Gut 2009, 58:1680-1689.
15. Geyer J.T., Ferry J.A., Harris N.L., et al. Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease. Am J Surg Pathol 2010, 34:202-210.
16. Masaki Y., Dong L., Kurose N., et al. Proposal for a new clinical entity. IgG4-positivemultiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 2009, 68:1310-1315.
17. Wallace Z.S., Khosroshahi A., Jakobiec F.A., et al. IgG4-related systemic disease as a cause of "idiopathic" idiopathic orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophtalmol 2011, 57:26-33.
18. Hermet M., Andre M., Kemeny J.L., et al. Is IgG4-related disease a cause of xerostomia? A cohort study of 60 patients. Int J Rheumatol 2012, 1-6.
19. Masaki Y., Sugai S., Umehara H. IgG4-related diseases including Mikulicz's disease and sclerosing pancreatitis: diagnostic insights. J Rheumatol 2010, 37:1380-1385.
20. Fatourechi M.M., Hay I.D., Mclver B., et al. Invasive fibrous thyroiditis (Riedel thyroiditis): the Mayo Clinic experience, 1976-2008. Thyroid 2011, 21:765-772.
21. Dahlgren M., Khosroshahi A., Nielsen G.P., et al. Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res 2010, 62:1312-1318.
22. Saeki T., Nishi S., Imai N., et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int 2010, 78:1016-1023.
23. Nishi S., Imai N., Yoshida K., et al. Clinicopathological findings of immunoglobulin G4-related kidney disease. Clin Exp Nephrol 2011, 15:810-819.
24. Takahashi N., Kawashima A., Flechter J.G., et al. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 2007, 242:791-801.
25. Uehara T., Hamano H., Kawakami M., et al. Autoimmune pancreatitis-associated prostatitis: distinct clinicopathological entity. Pathology international 2008, 58:118-125.
26. Yi E.S., Sekiguchi H., Peikert T., et al. Pathologic manifestations of IgG4-related lung disease. Semin Diagn Pathol 2012, 29:219-225.
27. Hufnagel M., Henneke P., Schmitt-Graeff A. IgG4-related disease. N Engl J Med 2012, 366:1643-1644.
28. Taki H., Matsui S., Shinoda K., et al. Comment on: arthropathy with infiltrate IgG4-positive plasma cells in synovium. Rheumatology (Oxford) 2012, 51:1922-1924. [author reply 1924-5].
29. Umekita K., Kaneko Y., Yorita K., et al. Comment on arthropathy with infitrate IgG4-positive plasma cells in synovium: reply. Rheumatology (Oxford) 2012, 51:1924-1925.
30. Umekita K., Kaneko Y., Yorita K., et al. Arthropathy with infiltrate IgG4-positive plasma cells in synovium. Rheumatology (Oxford) 2012, 51:58-62.
31. Shinoda K., Matsui S., Taki H., et al. Deforming arthropathy in a patient with IgG4-related systemic disease: comment on the article by Stone et al. Arthritis Care Res (Hoboken) 2010, 63:172.
32. Fujimori N., Ito T., Igarashi H., et al. Retroperitoneal fibrosis associated with immunoglobulin G4-related disease. World J Gastroenterol 2013, 19:35-41.
33. Stone J.H. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol 2010, 23:88-94.
34. Ebbo M., Daniel L., Pavic M., et al. IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine (Baltimore) 2012, 91:49-56.
35. Stone J.H., Zen Y., Deshpande V. IgG4-related disease. N Engl J Med 2012, 366:539-551.
36. Khosroshahi A., Stone J.H. Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol 2010, 23:67-71.
37. Khosroshahi A., Carruthers M.N., Deshpande V., et al. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) 2012, 91:57-66.
38. Murakami J., Matsui S., Ishizawa S., et al. Recurrence of IgG4-related disease following treatment with rituximab. Mod Rheumatol 2012.
39. Khosroshahi A., Bloch D.B., Deshpande V., et al. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010, 62:1755-1762.
40. Khan M.L., Colby T.V., Viggiano R.W., et al. Treatment with bortezomib of a patient having hyper IgG4 disease. Clin Lymphoma Myeloma Leuk 2010, 10:217-219.
41. Khosroshahi A., Ayalon R., Beck L.H., et al. IgG4-related disease is not associated with antibody to the phospholipase A2 receptor. Int J Rheumatol 2012, 1-5.
42. Okazaki K., Uchida K. Immunological aspects of IgG4-related disease. Curr Immunol Rev 2011, 7:204-211.